Akero Therapeutics, Inc.

BIT:1AKRO Stock Report

Market Cap: €2.9b

Akero Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BIT:1AKRO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
27 Mar 25Buy€8,141,130Logos Global Management, L.P.Company200,000€41.45
12 Mar 25Sell€21,213Timothy RolphIndividual516€41.11
12 Mar 25Sell€27,790William WhiteIndividual676€41.11
12 Mar 25Sell€25,242Catriona YaleIndividual614€41.11
12 Mar 25Sell€24,954Jonathan YoungIndividual607€41.11
12 Mar 25Sell€71,449Andrew ChengIndividual1,738€41.11
30 Jan 25Buy€9,209,280Logos Global Management, L.P.Company200,000€46.05
02 Jan 25Sell€273,350Jonathan YoungIndividual10,000€27.33
10 Dec 24Sell€82,555William WhiteIndividual2,817€29.31
10 Dec 24Sell€69,396Timothy RolphIndividual2,368€29.31
10 Dec 24Sell€230,198Andrew ChengIndividual7,855€29.31
10 Dec 24Sell€73,353Jonathan YoungIndividual2,503€29.31
10 Dec 24Sell€82,350Catriona YaleIndividual2,810€29.31
10 Dec 24Sell€27,108Patrick LamyIndividual925€29.31
10 Sep 24Sell€41,274Andrew ChengIndividual1,738€23.75
10 Sep 24Sell€12,753Timothy RolphIndividual537€23.75
10 Sep 24Sell€15,175William WhiteIndividual639€23.75
10 Sep 24Sell€15,127Catriona YaleIndividual637€23.75
10 Sep 24Sell€13,489Jonathan YoungIndividual568€23.75
11 Jun 24Sell€166,628Andrew ChengIndividual7,894€21.11
11 Jun 24Sell€50,238Timothy RolphIndividual2,380€21.11
11 Jun 24Sell€12,011Patrick LamyIndividual569€21.11
11 Jun 24Sell€59,755William WhiteIndividual2,831€21.11
11 Jun 24Sell€59,631Catriona YaleIndividual2,825€21.11
11 Jun 24Sell€53,108Jonathan YoungIndividual2,516€21.11

Insider Trading Volume

Insider Buying: 1AKRO insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1AKRO?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,047,5421.3%
VC/PE Firms5,233,9896.52%
Hedge Funds6,859,8238.54%
Institutions67,151,60383.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.3%.

Top Shareholders

Top 25 shareholders own 78.91% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.61%
RTW Investments, LP
6,859,823€245.9m15.9%4.34%
7.85%
BlackRock, Inc.
6,254,978€224.2m5.58%no data
7.57%
Janus Henderson Group plc
6,034,239€216.3m-14.7%0.1%
7.45%
Wellington Management Group LLP
5,936,240€212.8m-19.5%0.04%
6.57%
General Atlantic Service Company, L.P.
5,233,989€187.6m0%4.52%
6.26%
T. Rowe Price Group, Inc.
4,992,020€178.9m-2.28%0.02%
5.31%
The Vanguard Group, Inc.
4,230,644€151.6m14.2%no data
2.93%
State Street Global Advisors, Inc.
2,335,944€83.7m-6.67%no data
2.79%
UBS Asset Management AG
2,227,857€79.8m403%0.01%
2.31%
AllianceBernstein L.P.
1,839,281€65.9m-8.82%0.02%
2.19%
Geode Capital Management, LLC
1,749,194€62.7m12.2%no data
1.87%
Deep Track Capital, LP
1,490,000€53.4m116%2.51%
1.85%
Alkeon Capital Management, LLC
1,476,618€52.9m-47.1%0.38%
1.7%
Citadel Advisors LLC
1,354,893€48.6m804%0.05%
1.55%
Redmile Group, LLC
1,235,209€44.3m-11%4.12%
1.51%
Logos Global Management, L.P.
1,200,000€43.0m50%7.3%
1.49%
Perceptive Advisors LLC
1,185,592€42.5m-30.9%1.66%
1.45%
Societe Generale, Securities Investments
1,155,787€41.4m93.3%0.15%
1.38%
Baker Bros. Advisors LP
1,097,082€39.3m0%0.37%
1.27%
FMR LLC
1,008,979€36.2m2,510%no data
1.19%
Rock Springs Capital Management LP
946,499€33.9m1.4%1.58%
1.17%
Point72 Asset Management, L.P.
935,686€33.5m-28.8%0.08%
0.93%
Silverarc Capital Management, LLC
739,563€26.5m15.6%8.29%
0.9%
Long Focus Capital Management LLC
719,604€25.8m0%2.23%
0.84%
Yiheng Capital Management, L.P.
666,145€23.9m-12.2%4.78%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/16 14:43
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Akero Therapeutics, Inc. is covered by 18 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason ZemanskyBofA Global Research
Alexandria HammondBofA Global Research
Edward NashCanaccord Genuity